Previous 10 | Next 10 |
home / stock / iva / iva articles
On Friday, in its fourth-quarter 2023 earnings release, Inventiva SA (NASDAQ:IVA) said it has voluntarily paused screening and randomizat...
Shares of The Trade Desk, Inc. (NASDAQ: TTD) shares rose sharply in today’s pre-market trading after the company reported mixed fourth-quart...
U.S. stock futures were mixed this morning, with the Nasdaq futures trading higher by around 100 points on Friday. Shares of Yelp Inc. (NYSE: YEL...
Daix (France), Long Island City (New York, United States), January 24, 2024 – Inventiva (NASDAQ:IVA) (the "Company"), a clinical-stag...
Inventiva intends to use the proceeds to fund part of its ongoing pivotal NATiV3 Phase III clinical trial evaluating lanifibranor in patients wit...
The first patient was randomized in China in the NATiV3 Phase III clinical trial, triggering a milestone payment of $3 million from CTTQ to Inven...
The DMC recommended to continue the clinical trial without modification of the protocol, based on the pre-planned review of safety data The safet...
Cash and cash equivalents at €43.8 million, short-term deposits at €0.03 million2, and long-term deposit at €5.0 million3 as of September 3...
The phase II study led by Dr. Kenneth Cusi evaluating lanifibranor in patients with T2D and MASLD was selected as late breaker. Two additional sc...
News, Short Squeeze, Breakout and More Instantly...
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...
Novonix Limited (NVNXF) is expected to report for quarter end 2023-06-30 LifeWorks Inc (MSIXF) is expected to report for quarter end 2023-06-30 Arrival (ARVL) is expected to report for quarter end 2023-06-30 Treasure Global Inc. (TGL) is expected to report $-0.16 for Q4 2023 Manch...